AI
HIMSS23
ChatGPT has a lot of potential to improve healthcare, but it lacks the human touch and comes with ethical and legal issues, explains R. Ryan Sadeghian, CMIO of Hunterdon Healthcare System.
HIMSS23
Calum Yacoubian, director of healthcare strategy at IQVIA, outlines natural language processing use cases, such as aggregating data for population health initiatives and supporting rare disease diagnoses for precision medicine.
HIMSS23
John Gaines, VP of marketing at Cohere Health, describes the challenges providers face in getting prior authorizations and how new CMS guidelines will speed up the process by mandating that it be done electronically.
HIMSS23
Aaron Miri, SVP and chief digital and information officer at Baptist Health, discusses lessons his organization learned from HIMSS23 cybersecurity forum and how it's leveraging that info to keep patient data secure.
HIMSS23
Tim O'Connell, CEO and founder of Emtelligent, talks about Emtelligent's NLP software, which is specially designed to understand medical English, and how it can assist drug companies with finding clinical trial cohorts from patient records.
HIMSS23
Dr. Colin Banas, chief medical officer at DrFirst, discusses how his company uses AI to automate tasks such as processing prescription refills, which prevents medication errors and reduces clinicians' administrative burden.
HIMSS23
Robert Stillman, director of clinical and research informatics at the Ohio State University Wexner Medical Center, discusses the challenges of chairing the Global Health Conference Education Committee for HIMSS23.
HIMSS23
Dr. Wonchul Cha, CMIO and director of the Digital Innovation Center, and Dr. Meong Hi Son, vice director of the Digital Transformation Center, both from Samsung Medical Center, explain how leveraging robots lessens nurses' workload.
HIMSS23
Kathleen McGrow, chief nursing information officer at Microsoft and 2023 Changemaker Award recipient, discusses the importance of studying workforce crisis in healthcare and how to use automation to streamline workflows.
HIMSS23
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.